"Danger in the Ring." According to Karen, a doctor in the emergency room asked her over the phone: “Was your daughter using birth control?” Karen said, “Yes, NuvaRing.” He removed the device and said, “I thought so, because she’s having a pulmonary embolism.” [more inside]
Feast your senses (including, perhaps, your sense of outrage) on this Merck Vioxx sales training video, presented in 3 parts without commercial interruption (heh) by the often interesting Pharmalot. [more inside]
In September 2001 the FDA warned Merck, makers of the painkiller Vioxx, for engaging in a promotional campaign that minimized "potentially serious cardiovascular findings." The previous year, Merck spent $161 million on Vioxx advertising (more than Pepsi or Budweiser spent on advertising that year). Earlier this year, a securities class action complaint was filed on behalf of several Merck investors alleging the company engaged in a marketing campaign that included false and misleading statements concerning the safety profile of Vioxx and that company insiders sold personally held shares of Merck for over $175 million in proceeds. Today, Merck withdrew Vioxx from the market.
Merck to lower prices of HIV drugs for Africa It's not perfect and it's not much of a decrease, but it's a start and long overdue.